Also, it would be good to know if upon completion of milestone 4 does that mean that the Medtronic board advisors role is done and no longer privy to discussions and inquiries from potential suitors. If that is the case, that would/could be a very precarious position for Medtronic bc they would not be aware of another company coming to Titan for IP, know how or even flat BO of ENOS, IP, Living labs R&D arm.
If milestone 4 is completed and nothing follows, I would expect ISRG, JnJ, Stryker, etc to come knocking to have private conversations w Titans board and executive team wo interference from Medtronic advisor.